For the Inventor, By the Inventor

Enter assignee name

Exton, PA, United States of America

Therakos, Inc.

USPTO Granted Patents = 31

% Expired Patents = 9.7

CIPO Patents = 20

EPO Patents = 10

Trademarks = 2

Forward Citations = 1,606

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Dennis Briggs (14 out of 20 patents)

Livingston B Morris (6 out of 8 patents)

Kyu H Lee (5 out of 5 patents)

4. Tom Watters (3 out of 4 patents)

5. Richard L Edelson (3 out of 24 patents)

6. Jerome B Zeldis (2 out of 63 patents)

7. Michael Scott Hutchinson (2 out of 19 patents)

8. Steve Gara (2 out of 3 patents)

9. Mike Hutchinson (2 out of 3 patents)

10. Stephen Gara (2 out of 2 patents)

11. Susan N McLaughlin (2 out of 2 patents)

12. Bruce C Stouch (2 out of 2 patents)

13. David Peritt (1 out of 30 patents)

14. Kim Campbell (1 out of 3 patents)

15. Amy Krutsick (1 out of 3 patents)

Core Competencies:

Photopheresis

Blood Component

Flow Pump

Biological Fluids

Phototherapy

Immune System

Light Energy

Fluid Separation

Irradiation

Centrifuge

Regulatory T Cells

Contaminant Detection

31 patents: Sort by Forward Citations

1. 9238097 - Method for collecting a desired blood component and performing a photopheresis treatment (2016-01-19),

2. 9169461 - Use of apoptotic cells ex vivo to generate regulatory T cells (2015-10-27),

3. 8722422 - Uninterrupted flow pump apparatus and method (2014-05-13),

4. 8481008 - Phototherapy compositions and methods (2013-07-09),

5. 8153083 - Uninterrupted flow pump apparatus and method (2012-04-10),

6. 7914477 - Apparatus for the continuous separation of biological fluids into components and method of using same (2011-03-29),

7. 7850634 - Method for collecting a desired blood component and performing a photopheresis treatment (2010-12-14),

8. 7534616 - Uninterrupted flow pump apparatus and method (2009-05-19),

9. 7479123 - Method for collecting a desired blood component and performing a photopheresis treatment (2009-01-20),

10. 7476209 - Method and apparatus for collecting a blood component and performing a photopheresis treatment (2009-01-13),

11. 7465285 - Control system for driving fluids through an extracorporeal blood circuit (2008-12-16),

12. 7211037 - Apparatus for the continuous separation of biological fluids into components and method of using same (2007-05-01),

13. 7186230 - Method and apparatus for the continuous separation of biological fluids into components (2007-03-06),

14. 6793643 - Low extracorporeal volume treatment system (2004-09-21),

15. 6495366 - Uninterrupted flow pump apparatus and method (2002-12-17),

Company Overview

Therakos, Inc. is a biotechnology company based in Exton, Pennsylvania, specializing in innovative immunotherapy solutions. The company focuses on developing and manufacturing medical devices and therapies that harness the power of the immune system to treat various diseases, particularly in the fields of autoimmune disorders and organ transplantation. Through its advanced technologies, Therakos aims to improve patient outcomes and enhance the quality of life for individuals with complex medical conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

31 Patents

#10 in Exton, PA

#397 in Pennsylvania

#10,927 in US

#21,260 in the World

Exton, PA, United States of America

Therakos, Inc.

Forward Citations = 1,606

25 inventors:

Dennis Briggs (14 out of 20 patents)

Livingston B Morris (6 out of 8 patents)

Kyu H Lee (5 out of 5 patents)

4. Tom Watters (3 out of 4 patents)

5. Richard L Edelson (3 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Therakos, Inc.. Retrieved from https://idiyas.com/company/therakos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…